Advertisement
CommentaryIn-Press Preview Free access | 10.1172/JCI137647
1Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, United States of America
Find articles by Pedersen, S. in: PubMed | Google Scholar
1Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, United States of America
Find articles by
Ho, Y.
in:
PubMed
|
Google Scholar
|
Published March 27, 2020 - More info
The pandemic coronavirus infectious disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly spreading across the globe. In this issue of the JCI, Chen and colleagues compared the clinical and immunologic characteristics between moderate versus severe COVID-19. The authors found that respiratory distress on admission is associated with unfavorable outcomes. Increased cytokine levels (IL-6, IL-10 and TNFα), lymphopenia (in CD4+ and CD8+ T cells), and decreased IFNγ expression in CD4+ T cells are associated with severe COVID-19. Overall, this study characterized the cytokine storm in severe COVID-19 and provides insights into immune therapeutics and vaccine design.